SCHEMBL22260445

SCHEMBL22260445

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc5c(c4)c4ccccc4c4ccc6c7ccc8ccccc8c7oc6c45)n3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 13/20 0.44
CYP1B1 Q16678 13/20 0.44
CYP1A2 P05177 12/20 0.44
ABCG2 Q9UNQ0 4/20 0.44
PRKDC P78527 3/20 0.44
ABCC1 P33527 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ABCB1 P08183 2/20 0.44
PDE5A O76074 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
CYP19A1 P11511 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
CYP2B6 P20813 1/20 0.44
TACR2 P21452 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097101 0.90 MEN1 (0.39) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL22260497 0.90 KMT2A (0.42) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL22260519 0.86 ABCG2 (0.43) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL22260520 0.86 ABCG2 (0.43) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL21186899 0.85 ALDH1A1 (0.42) CYP1A2KDM4EALDH1A1CYP3A4MAPT
SCHEMBL22097257 0.85 ALDH1A1 (0.42) CYP1A2KDM4EALDH1A1CYP3A4MAPT
SCHEMBL21186959 0.85 ALDH1A1 (0.42) CYP1A2KDM4EALDH1A1CYP3A4MAPT
SCHEMBL22260544 0.85 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL23597227 0.85 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL20228670 0.84 MAPT (0.41) CYP1A1CYP1B1CYP1A2ABCG2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME TRPA1, PIEZO1, SLCO4C1 CYP1A1 1422/4885CYP1B1 2003/4885CYP1A2 1799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.